Compare AKA & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AKA | RPID |
|---|---|---|
| Founded | 2018 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.4M | 102.6M |
| IPO Year | 2021 | 2021 |
| Metric | AKA | RPID |
|---|---|---|
| Price | $10.78 | $1.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $24.33 | $8.00 |
| AVG Volume (30 Days) | 2.1K | ★ 241.6K |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2.78 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $600,208,000.00 | $33,587,000.00 |
| Revenue This Year | $6.14 | $19.12 |
| Revenue Next Year | $4.89 | $18.42 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 4.44 | ★ 19.74 |
| 52 Week Low | $8.42 | $1.66 |
| 52 Week High | $16.38 | $4.94 |
| Indicator | AKA | RPID |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 53.24 |
| Support Level | N/A | $1.98 |
| Resistance Level | N/A | $2.17 |
| Average True Range (ATR) | 0.00 | 0.15 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 53.57 |
a.k.a. Brands Holding Corp is a portfolio of fashion brands, including Princess Polly, Culture Kings, Petal & Pup, and mnml. Through these brands, the company reaches next-generation consumers who seek fashion inspiration on social media and mainly shop online. The portfolio consists of two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company generates the majority of its revenue from the United States.
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.